Loading...
Internationally Recognized Certificates of Compliance (IRCC)
  |  
last updated: 14 Nov 2018
General Information
ABSCH-IRCC-IN-241112-1
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Details of the permit or its equivalent
India/NBA/Appl/9/1082

Application in Form-III for seeking approval for the invention Synthesis and Biological activity (Anti-bacterial and Anti-fungal) of Schiff-Base metal complexes for obtaining IP Rights in India 

Indian Patent Application Number: 347/MUM/2013


11 Jan 2017
Prior Informed Consent (PIC) Information
Yes
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Confidential information
- Person: Dr Ajit Hirachand Manikshete | ABSCH-CON-IN-240437-2
Person:
Dr Ajit Hirachand Manikshete
Harshal Plot no. 20, ChakravarthiHsg. Near D.A.V. College
Solapur, Maharashtra
413002, India
Phone: +91 9422460706,
Fax:
Website:
Confidential information
Mutually Agreed Terms (MAT) Information
Yes
1. The user shall notify the NBA within 60 days from the date of grant of IPR and also assignment or license of the IPR to any person, if any

2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes. 

3. The user shall inform the NBA about any commercialization made on the IP Rights granted within 45 days from the date of such event.

4. The user shall submit annual report to NBA as per the terms and conditions agreed upon.   


Subject-matter or genetic resource(s)
Confidential information
Information on the utilization of the genetic resource(s)
  • Commercial

1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee. 

  

2. In case the user assigns or transfers the IPR to any person, the user undertakes to attach this agreement as an appendix to the assignment instrument which shall be binding upon such person and inform the NBA within 60 days from the date of such transfer.


Additional Information
Amendment history
Unique identifier Status Date
ABSCH-IRCC-IN-241112-1
REVOKED OLD VERSION PUBLISHED DELETED
Sujata Arora (sujata@nic.in)
14 Nov 2018 09:03
on 14 Nov 2018 09:03